Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir.
Orofino G, Xue E, Doglio M, Noviello M, Tassi E, Cristante M, Acerbis A, Clerici D, Farina F, Campodonico E, Bruno A, Piemontese S, Mastaglio S, Diral E, Milani R, Ruggeri A, Corti C, Vago L, Bonini C, Peccatori J, Ciceri F, Lupo Stanghellini MT, Greco R. Orofino G, et al. Among authors: farina f. Bone Marrow Transplant. 2023 Oct;58(10):1104-1111. doi: 10.1038/s41409-023-02046-9. Epub 2023 Jul 19. Bone Marrow Transplant. 2023. PMID: 37468541
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Clerici D, Oltolini C, Greco R, Ripa M, Giglio F, Mastaglio S, Lorentino F, Pavesi F, Farina F, Liberatore C, Castiglion B, Tassan Din C, Bernardi M, Corti C, Peccatori J, Scarpellini P, Ciceri F, Castagna A. Clerici D, et al. Among authors: farina f. Int J Antimicrob Agents. 2021 Jun;57(6):106335. doi: 10.1016/j.ijantimicag.2021.106335. Epub 2021 Apr 7. Int J Antimicrob Agents. 2021. PMID: 33838223
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Greco R, Lorentino F, Albanese S, Lupo Stanghellini MT, Giglio F, Piemontese S, Clerici D, Lazzari L, Marcatti M, Mastaglio S, Xue E, Farina F, Pavesi F, Assanelli A, Carrabba MG, Marktel S, Vago L, Bonini C, Corti C, Bernardi M, Ciceri F, Peccatori J. Greco R, et al. Among authors: farina f. Transplant Cell Ther. 2021 Sep;27(9):776.e1-776.e13. doi: 10.1016/j.jtct.2021.05.023. Epub 2021 Jun 1. Transplant Cell Ther. 2021. PMID: 34087452 Free article.
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
Lupo-Stanghellini MT, Xue E, Mastaglio S, Oltolini C, Angelillo P, Messina C, Piemontese S, Girlanda S, Farina F, Lazzari L, Cicalese MP, Erbella F, Greco R, Locatelli M, Milani R, Peccatori J, Corti C, Marktel S, Assanelli A, Ciceri F. Lupo-Stanghellini MT, et al. Among authors: farina f. Bone Marrow Transplant. 2021 Sep;56(9):2312-2315. doi: 10.1038/s41409-021-01278-x. Epub 2021 Jun 30. Bone Marrow Transplant. 2021. PMID: 34193980 Free PMC article. No abstract available.
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients.
Serpenti F, Lorentino F, Marktel S, Milani R, Messina C, Greco R, Girlanda S, Clerici D, Giglio F, Liberatore C, Farina F, Mastaglio S, Piemontese S, Guggiari E, Lunghi F, Marcatti M, Carrabba MG, Bernardi M, Bonini C, Assanelli A, Corti C, Peccatori J, Ciceri F, Lupo-Stanghellini MT. Serpenti F, et al. Among authors: farina f. Front Oncol. 2021 Jul 22;11:705568. doi: 10.3389/fonc.2021.705568. eCollection 2021. Front Oncol. 2021. PMID: 34367991 Free PMC article.
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type.
Lazzari L, Farina F, Lupo Stanghellini MT, Piemontese S, Marktel S, Mazzi B, Vago L, Milani R, Ferrario A, Bianchi B, Merli M, Ferreri AJM, Corti C, Peccatori J, Ruggeri A, Ciceri F. Lazzari L, et al. Among authors: farina f. Curr Res Transl Med. 2021 Oct;69(4):103313. doi: 10.1016/j.retram.2021.103313. Epub 2021 Sep 28. Curr Res Transl Med. 2021. PMID: 34598023 No abstract available.
Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients.
Xue E, Lorentino F, Clerici D, Farina F, Oltolini C, Giglio F, Campodonico E, Nitti R, Bernardi M, Corti C, Peccatori J, Ciceri F, Lupo Stanghellini MT, Greco R. Xue E, et al. Among authors: farina f. Bone Marrow Transplant. 2022 Jan;57(1):128-130. doi: 10.1038/s41409-021-01486-5. Epub 2021 Oct 8. Bone Marrow Transplant. 2022. PMID: 34625664 No abstract available.
Second Solid Cancers After Hematopoietic Stem Cell Transplantation: Active Surveillance During Long-term Follow-up.
Lupo-Stanghellini MT, Piemontese S, Assanelli A, Serpenti F, Mastaglio S, Clerici D, Giglio F, Greco R, Lorentino F, Pavesi F, Farina F, Marktel S, Corti C, Peccatori J, Ciceri F. Lupo-Stanghellini MT, et al. Among authors: farina f. Hemasphere. 2021 Oct 28;5(11):e654. doi: 10.1097/HS9.0000000000000654. eCollection 2021 Nov. Hemasphere. 2021. PMID: 34901758 Free PMC article. No abstract available.
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Lorentino F, Xue E, Mastaglio S, Giglio F, Clerici D, Farina F, Piemontese S, Bruno A, Lazzari L, Ruggeri A, Guggiari E, Lunghi F, Assanelli AA, Marktel S, Marcatti M, Carrabba MG, Bernardi M, Corti C, Peccatori J, Ciceri F, Greco R, Lupo-Stanghellini MT. Lorentino F, et al. Among authors: farina f. Blood Adv. 2022 May 24;6(10):3053-3057. doi: 10.1182/bloodadvances.2021006213. Blood Adv. 2022. PMID: 35078219 Free PMC article. No abstract available.
432 results